IRF5 and systemic lupus erythematosus: In summary, we have demonstrated that there was a critical threshold level of IRF5 in B cells that was required for disease development in the FcγRIIB−/−Yaa mouse lupus model and that IRF5 nuclear translocation was substantially reduced in B cells from IRF5-heterozygous mice after TLR7 activation.